SAGA Diagnostics AB – Trademark Portfolio
Entity Type: 03
SAGA Diagnostics AB holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include SAGASEQ, SAGASAFE, SAGASIGN, and SAGA DIAGNOSTICS.
Medicon Village,
Scheelevägen 2 SE-223 81 Lund
Showing of trademarks Trademarks
Trademark Classifications
SAGA Diagnostics AB's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SAGA Diagnostics AB have?
SAGA Diagnostics AB has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending.
What trademark classes does SAGA Diagnostics AB file in?
SAGA Diagnostics AB files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SAGA Diagnostics AB's most well-known trademarks?
SAGA Diagnostics AB's registered trademark portfolio includes well-known marks such as SAGASEQ, SAGASAFE, SAGASIGN, and SAGA DIAGNOSTICS. These are among 5 currently registered trademarks in the portfolio.
What is SAGA Diagnostics AB's trademark registration success rate?
SAGA Diagnostics AB has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.